Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin concentrations in interstitial space fluid of septic patients
2010-022150-16Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Aug 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of moxifloxacin in sepsis, sponsored by Medical University of Vienna. Primary endpoint: Pharmacokinetic parameters in microdialysate and plasma. Started Aug 2010; status: terminated.
02
Drugs
moxifloxacin
03
Conditions
sepsis
Beyond the preview
Go deeper on 2010-022150-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022150-16.